Advertisement

Uveitis pp 187-190 | Cite as

Type I Hypersensitivity

  • E. Mitchel Opremcak

Abstract

Most of the disorders that have a type I hypersensitivity reaction as the predominant pathophysiologic mechanism are inflammatory diseases of the ocular surface. The choroid has a population of mast cells; however, their role in uveitis and retinal edema is not well defined.1

Keywords

Atopic Dermatitis Nedocromil Sodium Allergic Conjunctivitis Cromolyn Sodium Disodium Cromoglycate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    de Kozak Y, Sainte-Laudy J, Benveniste J, Faure J-P. Evidence for immediate hypersensitivity phenomena in experimental autoimmune uveoretinitis. Eur J Immunol. 1981; 11: 612.PubMedCrossRefGoogle Scholar
  2. 2.
    Allansmith MR, Abelson MB. Ocular aller-gies. In: Smolin G, Thoft RA, eds. The Cornea: Scientific Foundations and Clinical Practice. 2nd ed. Boston: Little, Brown; 1987.Google Scholar
  3. 3.
    Gell PGH, Coombs RRA, eds. Clinical Aspects of Immunology. Oxford: Blackwell; 1968.Google Scholar
  4. 4.
    Hogan MJ. Atopic keratoconjunctivitis. Am J Ophthalmol. 1953; 36: 937.PubMedGoogle Scholar
  5. 5.
    Blumenthal M, Casale T, Dockhorn R, et al. Efficacy and safety of nedocromil sodium ophthalmic solution in the treatment of seasonal allergic conjunctivitis. Am J Ophthalmol. 1992; 113: 56.PubMedGoogle Scholar
  6. 6.
    Friday GA, Biglan AW, Hiles DA, et al. Treatment of ragweed allergic conjunctivitis with cromolyn sodium 4% ophthalmic solution. Am J Ophthalmol. 1983; 95: 169.PubMedCrossRefGoogle Scholar
  7. 7.
    Cox J. Disodium cromoglycate (FPL670) (Intal): a specific inhibitor of reaginic anti-gen-antibody mechanisms. Nature. 1967; 216: 1329.CrossRefGoogle Scholar
  8. 8.
    Bernstein IL, Siegel SC, Blanden ML, et al. A controlled study of cromolyn sodium sponsored by the drug committee of the American Academy of Allergy. J Allergy Clin Immunol. 1972; 50: 235.PubMedCrossRefGoogle Scholar
  9. 9.
    Handleman NI, Friday GA, Schwartz HJ, et al. Cromolyn sodium nasal solution in the prophylactic treatment of pollen induced seasonal allergic rhinitis. J Allergy Clin Immunol. 1977; 59: 237.CrossRefGoogle Scholar
  10. 10.
    Caldwell DR, Verin P, Hartwich-Young R, et al. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Am J Ophthalmol. 1992; 113: 632.PubMedGoogle Scholar
  11. 11.
    Hogan MJ. Atopic keratoconjunctivitis. Am J Ophthalmol. 1953; 50: 937.Google Scholar
  12. 12.
    Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmology. 1990; 97: 992.PubMedGoogle Scholar
  13. 13.
    Beethan WP. Atopic cataract. Arch Ophthalmol. 1940; 24: 21.Google Scholar
  14. 14.
    Braude LS, Chandler JW. Atopic corneal disease. Int Ophthalmol Clin. 1984; 24: 145.PubMedGoogle Scholar
  15. 15.
    Rich LF, Hanifin JM. Ocular complications of atopic dermatitis and other eczemas. Int Ophthalmol Clin. 1985; 25: 61.PubMedCrossRefGoogle Scholar
  16. 16.
    Aswad MI, Tauber J, Baum J. Plasmaphere-sis treatment in patients with severe atopic keratoconjunctivitis. Ophthalmology. 1988; 95: 444.PubMedGoogle Scholar
  17. 17.
    Foster CS. Vernal keratoconjunctivitis. Perspect Ophthalmol. 1980; 4: 35.Google Scholar
  18. 18.
    Ballow M, Donshik PC, Mendelson L, et al. IgG specific antibodies to rye grass and ragweed pollen antigens in the tear secretions of patients with vernal conjunctivitis. Am J Ophthalmol. 1983; 95: 161.PubMedCrossRefGoogle Scholar
  19. 19.
    Trocme SD, Kephart GM, Bourne WM, et al. Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. Am J Ophthalmol. 1993; 115: 640.PubMedGoogle Scholar
  20. 20.
    Foster CS, Duncan J. Randomized clinical trial of topically administered cromolyn sodium for vernal keratoconjunctivitis. Am J Ophthalmol. 1980; 90: 175.PubMedGoogle Scholar
  21. 21.
    Bleik JH, Tabbara KF. Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology. 1991; 98: 1679.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1995

Authors and Affiliations

  • E. Mitchel Opremcak
    • 1
  1. 1.The Ohio State UniversityColumbusUSA

Personalised recommendations